SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Checkley W)
 

Sökning: WFRF:(Checkley W) > Antiphospholipid an...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005058naa a2200769 4500
001oai:gup.ub.gu.se/310668
003SwePub
008240528s2021 | |||||||||||000 ||eng|
024a https://gup.ub.gu.se/publication/3106682 URI
024a https://doi.org/10.1016/j.eclinm.2021.1010702 DOI
040 a (SwePub)gu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Benjamin, L. A.4 aut
2451 0a Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study
264 1b Elsevier BV,c 2021
520 a Background: A high prevalence of antiphospholipid antibodies has been reported in case series of patients with neurological manifestations and COVID-19; however, the pathogenicity of antiphospholipid antibodies in COVID-19 neurology remains unclear. Methods: This single-centre cross-sectional study included 106 adult patients: 30 hospitalised COVID-neurological cases, 47 non-neurological COVID-hospitalised controls, and 29 COVID-non-hospitalised controls, recruited between March and July 2020. We evaluated nine antiphospholipid antibodies: anticardiolipin antibodies [aCL] IgA, IgM, IgG; anti-beta-2 glycoprotein-1 [a beta(2)GPI] IgA, IgM, IgG; anti-phosphatidylserine/prothrombin [aPS/PT] IgM, IgG; and anti-domain I b2GPI (aD1 beta 2GPI) IgG. Findings: There was a high prevalence of antiphospholipid antibodies in the COVID-neurological (73.3%) and non-neurological COVID-hospitalised controls (76.6%) in contrast to the COVID-non-hospitalised controls (48.2%). aPS/PT IgG titres were significantly higher in the COVID-neurological group compared to both control groups (p < 0.001). Moderate-high titre of aPS/PT IgG was found in 2 out of 3 (67%) patients with acute disseminated encephalomyelitis [ADEM]. aPS/PT IgG titres negatively correlated with oxygen requirement (FiO(2) R=-0.15 p = 0.040) and was associated with venous thromboembolism (p = 0.043). In contrast, aCL IgA (p < 0.001) and IgG (p < 0.001) was associated with non-neurological COVID-hospitalised controls compared to the other groups and correlated positively with D-dimer and creatinine but negatively with FiO(2). Interpretation: Our findings show that aPS/PT IgG is associated with COVID-19-associated ADEM. In contrast, aCL IgA and IgG are seen much more frequently in non-neurological hospitalised patients with COVID-19. Characterisation of antiphospholipid antibody persistence and potential longitudinal clinical impact are required to guide appropriate management. (C) 2021 The Author(s). Published by Elsevier Ltd.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskap0 (SwePub)3032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Health Sciences0 (SwePub)3032 hsv//eng
653 a guidelines
653 a thrombosis
653 a infection
653 a update
653 a risk
653 a General & Internal Medicine
700a Paterson, R. W.4 aut
700a Moll, R.4 aut
700a Pericleous, C.4 aut
700a Brown, R.4 aut
700a Mehta, P. R.4 aut
700a Athauda, D.4 aut
700a Ziff, O. J.4 aut
700a Heaney, J.4 aut
700a Checkley, A. M.4 aut
700a Houlihan, C. F.4 aut
700a Chou, M.4 aut
700a Heslegrave, A. J.4 aut
700a Chandratheva, A.4 aut
700a Michael, B. D.4 aut
700a Blennow, Kaj,d 1958u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xbleka
700a Vivekanandam, V.4 aut
700a Foulkes, A.4 aut
700a Mummerya, C. J.4 aut
700a Lunn, M. P.4 aut
700a Keddie, S.4 aut
700a Spyer, M. J.4 aut
700a McKinnon, T.4 aut
700a Hart, M.4 aut
700a Carletti, F.4 aut
700a Jager, H. R.4 aut
700a Manji, H.4 aut
700a Zandi, M. S.4 aut
700a Werring, D. J.4 aut
700a Nastoulik, E.4 aut
700a Simister, R.4 aut
700a Solomon, T.4 aut
700a Zetterberg, Henrik,d 1973u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xzethe
700a Schott, J. M.4 aut
700a Cohen, H.4 aut
700a Efthymiou, M.4 aut
710a Göteborgs universitetb Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi4 org
773t Eclinicalmedicined : Elsevier BVg 39q 39x 2589-5370
856u http://www.thelancet.com/article/S2589537021003503/pdf
8564 8u https://gup.ub.gu.se/publication/310668
8564 8u https://doi.org/10.1016/j.eclinm.2021.101070

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy